Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

356
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
356
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

992
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
992
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

667
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
667
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

216
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
216
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

778
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
778
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

2.5K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive assessment of lifecourse and mortality of Parkinson's disease in the German National Cohort.

NPJ Parkinson's disease·2026
Same author

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

NPJ Parkinson's disease·2026
Same author

Genetic Testing by Age at Onset in Parkinson Disease.

JAMA neurology·2026
Same author

Temporal dynamics of cognitive functioning in people with Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Correction: Making the invisible visible: integrated visualization and automated quantification of thrombus deformation during mechanical thrombectomy.

Frontiers in medical technology·2026
Same author

MDS Global Survey on Work Environment, Career Advancement, and Work-Life Balance in Movement Disorders Professionals: Gender and Regional Patterns.

Movement disorders clinical practice·2026

Related Experiment Video

Updated: Dec 9, 2025

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.1K

[Update on restless legs syndrome].

Michael Bartl1, Claudia Trenkwalder2,3, Maria-Lucia Muntean2

  • 1Klinik für Klinische Neurophysiologie und Klinik für Neurologie, Universitätsmedizin Göttingen, Robert Koch Str. 40, 37075, Göttingen, Deutschland. michael.bartl@med.uni-goettingen.de.

Der Nervenarzt
|September 15, 2020
PubMed
Summary

Restless legs syndrome (RLS) is a common neurological disorder causing an urge to move legs, impacting sleep and quality of life. Diagnosis is clinical, with iron deficiency screening and specific medications for treatment.

Keywords:
AugmentationPathophysiologyPregnancySleep disorderTreatment

More Related Videos

Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study
08:40

Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study

Published on: November 11, 2022

1.4K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

748

Related Experiment Videos

Last Updated: Dec 9, 2025

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.1K
Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study
08:40

Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study

Published on: November 11, 2022

1.4K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

748

Area of Science:

  • Neurology
  • Sleep Medicine
  • Clinical Diagnosis

Background:

  • Restless legs syndrome (RLS) affects up to 10% of the population, presenting as a common neurological disease and sleep-related movement disorder.
  • Symptoms include an irresistible urge to move the legs, sensory disturbances, and significant sleep disruption, leading to a reduced quality of life.
  • RLS often co-occurs with other internal and neurological conditions, highlighting its complex nature.

Purpose of the Study:

  • To provide a comprehensive overview of Restless Legs Syndrome (RLS).
  • To outline diagnostic criteria and current treatment strategies for RLS.
  • To address the management of RLS complications and its prevalence in specific populations.

Main Methods:

  • Clinical diagnosis based on five essential criteria.
  • Exclusion of iron deficiency as a primary step in management.
  • Review of approved pharmacological treatments including dopaminergics, dopamine agonists, and oxycodone/naloxone.

Main Results:

  • RLS is diagnosed clinically, with iron deficiency being a key factor to rule out.
  • Approved treatments include dopaminergics and dopamine agonists, with oxycodone/naloxone for severe cases.
  • Augmentation, a complication of dopaminergic therapy, requires specific management.

Conclusions:

  • RLS is a prevalent condition impacting quality of life, necessitating clinical diagnosis and targeted treatment.
  • Management involves addressing underlying causes like iron deficiency and utilizing approved medications.
  • Special attention is required for RLS complications and its significant prevalence in pregnant women (up to 25%).